Analysts expect that LifePoint Health, Inc. (NASDAQ:LPNT) will report $1.60 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have provided estimates for LifePoint Health’s earnings. The lowest sales estimate is $1.58 billion and the highest is $1.61 billion. LifePoint Health reported sales of $1.59 billion during the same quarter last year, which indicates a positive year over year growth rate of 0.6%. The company is expected to issue its next quarterly earnings report on Friday, October 27th.

On average, analysts expect that LifePoint Health will report full-year sales of $1.60 billion for the current fiscal year, with estimates ranging from $6.44 billion to $6.49 billion. For the next year, analysts anticipate that the company will report sales of $6.61 billion per share, with estimates ranging from $6.48 billion to $6.72 billion. Zacks’ sales calculations are an average based on a survey of research firms that that provide coverage for LifePoint Health.

LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.06. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company earned $0.69 earnings per share. LifePoint Health’s quarterly revenue was up .2% compared to the same quarter last year.

A number of equities analysts recently weighed in on LPNT shares. ValuEngine raised shares of LifePoint Health from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. BidaskClub lowered shares of LifePoint Health from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a research note on Monday, August 21st. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and issued a $66.00 target price on shares of LifePoint Health in a research note on Wednesday. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $66.40.

In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of the business’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the sale, the chairman now directly owns 439,841 shares of the company’s stock, valued at approximately $28,616,055.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 8.76% of the company’s stock.

Large investors have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in LifePoint Health by 10.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after buying an additional 164 shares in the last quarter. LS Investment Advisors LLC lifted its position in LifePoint Health by 43.7% during the 2nd quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after buying an additional 543 shares in the last quarter. US Bancorp DE lifted its position in LifePoint Health by 1.6% during the 1st quarter. US Bancorp DE now owns 1,931 shares of the company’s stock worth $127,000 after buying an additional 30 shares in the last quarter. Bank of Montreal Can lifted its position in LifePoint Health by 18.7% during the 1st quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock worth $128,000 after buying an additional 306 shares in the last quarter. Finally, Shelton Capital Management bought a new stake in LifePoint Health during the 2nd quarter worth about $205,000. 99.53% of the stock is currently owned by hedge funds and other institutional investors.

Shares of LifePoint Health (LPNT) traded down 0.09% during mid-day trading on Thursday, hitting $57.70. The company had a trading volume of 202,785 shares. The firm’s 50-day moving average price is $56.94 and its 200 day moving average price is $61.36. LifePoint Health has a one year low of $50.60 and a one year high of $70.95. The company has a market capitalization of $2.31 billion, a P/E ratio of 12.92 and a beta of 0.84.

TRADEMARK VIOLATION WARNING: “Brokerages Anticipate LifePoint Health, Inc. (LPNT) Will Post Quarterly Sales of $1.60 Billion” was reported by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/10/05/brokerages-anticipate-lifepoint-health-inc-lpnt-will-post-quarterly-sales-of-1-60-billion.html.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.